CLEMENTINE
DEAD

Serial Number

79310040

Owner

Guangdong Joyan Biological Technology Co., Ltd

Filing Date

Mar 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CLEMENTINE Trademark

Serial Number: 79310040

CLEMENTINE is a trademark filed by Guangdong Joyan Biological Technology Co., Ltd on March 22, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning). The application is currently no longer active.

Owner Contact Info

Guangdong Joyan Biological Technology Co., Ltd (2 trademarks)

Plant 3, No. 44-5, Area A, Manufacturing Base,

Entity Type: 03

Trademark Details

Filing Date

March 22, 2021

Registration Date

Not Registered

Goods & Services

Cakes of toilet soap; cleansing milk for toilet purposes; shampoos; essential oils; cosmetics; beauty masks; dentifrices; air fragrancing preparations; mouthwashes, not for medical purposes; breath freshening sprays; facial cleanser

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 3, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jun 12, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 31, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 12, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 12, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 10, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 10, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 10, 2022 ABN2
REFUSAL PROCESSED BY IB
Dec 21, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 26, 2021 RFCS
REFUSAL PROCESSED BY MPU
Nov 26, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 18, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 11, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 8, 2021 REPR